Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126584711 | 12658471 | 1 | I | 20160815 | 20160817 | 20160817 | EXP | IL-ROCHE-1814317 | ROCHE | , KLEINSTERN G, OREVI M, PALTIEL O, BEN-YEHUDA D, GURAL A, LIBSTER D, LAVIE D AND GATT M FAVORABLE OUTCOME OF PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH SEQUENTIAL RCHOP-RICE REGIMEN WITHOUT RADIOTHERAPY.. CANCER CHEMOTHERAPY AND PHARMACOLOGY 2016 APR 07;77(507):1053-1060. | 0.00 | Y | 0.00000 | 20160817 | MD | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126584711 | 12658471 | 1 | PS | Rituximab | RITUXIMAB | 1 | Unknown | U | 103705 | ||||||||||
| 126584711 | 12658471 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 3 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 7 | SS | BLEOMYCIN | BLEOMYCIN SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 8 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | 0 | ||||||||||
| 126584711 | 12658471 | 9 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126584711 | 12658471 | 1 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 2 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 3 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 4 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 5 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 6 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 7 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 8 | Primary mediastinal large B-cell lymphoma |
| 126584711 | 12658471 | 9 | Primary mediastinal large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126584711 | 12658471 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126584711 | 12658471 | Infection | |
| 126584711 | 12658471 | Liver function test increased | |
| 126584711 | 12658471 | Neuropathy peripheral | |
| 126584711 | 12658471 | Neutrophil count decreased | |
| 126584711 | 12658471 | Stomatitis | |
| 126584711 | 12658471 | Superior vena cava syndrome | |
| 126584711 | 12658471 | Thrombocytopenia | |
| 126584711 | 12658471 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |